We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
- Authors
Chaari, Anis; Pham, Tài; Mnif, Basma; Chtara, Kamilia; Medhioub, Fatma; Baccouche, Najeh; Bahloul, Mabrouk; Hammami, Adnène; Bouaziz, Mounir
- Abstract
The article discusses research which investigated outcomes associated with the combined use of colistin and tigecycline or colistin and imipenem/cilastatin for the treatment of Acinetobacter baumannii (Ab)-related ventilator-acquired pneumonia (VAP). Topics explored include the intensive care unit (ICU) admission of patients involved in the study, the drug dosage and combination regimens administered to patients, and the Ab bloodstream infections noted following treatment.
- Subjects
TUNISIA; ANTIBIOTICS; ACINETOBACTER infections; COMBINATION drug therapy; DRUG resistance in microorganisms; PROGNOSIS; SURVIVAL analysis (Biometry); RETROSPECTIVE studies; SALVAGE therapy; GRAM-negative aerobic bacteria; MINOCYCLINE; COLISTIN; CILASTATIN; IMIPENEM; VENTILATOR-associated pneumonia; THERAPEUTICS
- Publication
Intensive Care Medicine, 2015, Vol 41, Issue 11, p2018
- ISSN
0342-4642
- Publication type
research
- DOI
10.1007/s00134-015-4010-z